PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11435219-0	2001	Role of p38 MAP kinase in diperoxovanadate-induced phospholipase D activation in endothelial cells.	diperoxovanadate	26-42	glycosylphosphatidylinositol specific phospholipase D1	Homo sapiens	51-66	
11435219-1	2001	We previously demonstrated that diperoxovanadate (DPV), a synthetic peroxovanadium compound and cell-permeable oxidant that acts as a protein tyrosine phosphatase inhibitor and insulinomimetic, increased phospholipase D (PLD) activation in endothelial cells (ECs).	diperoxovanadate	32-48	glycosylphosphatidylinositol specific phospholipase D1	Homo sapiens	204-219	
11435219-1	2001	We previously demonstrated that diperoxovanadate (DPV), a synthetic peroxovanadium compound and cell-permeable oxidant that acts as a protein tyrosine phosphatase inhibitor and insulinomimetic, increased phospholipase D (PLD) activation in endothelial cells (ECs).	diperoxovanadate	32-48	glycosylphosphatidylinositol specific phospholipase D1	Homo sapiens	221-224	
11435219-1	2001	We previously demonstrated that diperoxovanadate (DPV), a synthetic peroxovanadium compound and cell-permeable oxidant that acts as a protein tyrosine phosphatase inhibitor and insulinomimetic, increased phospholipase D (PLD) activation in endothelial cells (ECs).	diperoxovanadate	50-53	glycosylphosphatidylinositol specific phospholipase D1	Homo sapiens	204-219	
11435219-1	2001	We previously demonstrated that diperoxovanadate (DPV), a synthetic peroxovanadium compound and cell-permeable oxidant that acts as a protein tyrosine phosphatase inhibitor and insulinomimetic, increased phospholipase D (PLD) activation in endothelial cells (ECs).	diperoxovanadate	50-53	glycosylphosphatidylinositol specific phospholipase D1	Homo sapiens	221-224	
11435219-2	2001	In this report, the regulation of DPV-induced PLD activation by mitogen-activated protein kinases (MAPKs) was investigated.	diperoxovanadate	34-37	glycosylphosphatidylinositol specific phospholipase D1	Homo sapiens	46-49	
11435219-4	2001	Treatment of ECs with p38 MAPK inhibitors SB-203580 and SB-202190 or transient transfection with a p38 dominant negative mutant mitigated the PLD activation by DPV but not by phorbol ester.	diperoxovanadate	160-163	glycosylphosphatidylinositol specific phospholipase D1	Homo sapiens	142-145	
11228747-3	1999	Previously, we have shown that ROS (hydrogen peroxide, fatty acid hydroperoxide, diperoxovanadate, and 4-hydroxynonenal) enhance protein tyrosine phosphorylation and activate phospholipase D (PLD) in bovine pulmonary artery endothelial cells (BPAECs).	diperoxovanadate	81-97	glycosylphosphatidylinositol specific phospholipase D1	Homo sapiens	192-195